Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis

Journal of Interferon and Cytokine Research

Volumn 27, Issue 1, 2007, Pages 65-75

  Banerjee, Kaustuv ^a,b   Biswas, Partha S ^a,c   Rouse, Barry T ^a,d  

^a UNIVERSITY OF TENNESSEE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; STAT4 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; HISTOPATHOLOGY; IMMUNOPATHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; SIGNAL TRANSDUCTION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALITIS, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, HUMAN; KERATITIS, HERPETIC; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MICE, SCID; SIGNAL TRANSDUCTION; STAT4 TRANSCRIPTION FACTOR; T-LYMPHOCYTE SUBSETS;

ANIMALIA; MURINAE; MUS; SIMPLEXVIRUS;

EID: 33846696721     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2007.0077     Document Type: Article

References (59)

1. Streilein JW, Dana MR, Ksander BR. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 1997;18:443-449.
2. Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev. Mol. Med. 2004;2004:1-14.
3. Russell RG, Nasisse MP, Larsen HS, Rouse BT. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 1984;25:938-944.
4. + T lymphocytes. Invest. Ophthalmol. Vis. Sci. 1992;33:2165-2173.
5. Niemialtowski MG, Rouse BT. Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis. J. Immunol. 1992;149:3035-3039.
6. Niemialtowski MG, Rouse BT. Phenotypic and functional studies on ocular T cells during herpetic infections of the eye. J. Immunol. 1992;148:8164-1870.
7. + T cell function between euthmic host and reconstituted SCID recipients. J. Immunol. 1998;160:3965-3970.
8. Kaplan MH. Stat4: a critical regulator of inflammation in vivo. Immunol. Res. 2005;31:231-242.
9. Babu JS, Kanangat S, Rouse BT. T cell cytokine mRNA expression during the course of the immunopathologic ocular disease herpetic stromal keratitis. J. Immunol. 1995;154:4822-4829.
10. Thomas J, Kanangat S, Rouse BT. Herpes simplex virus replication-induced expression of chemokines and proinflammatory cytokines in the eye: implications in herpetic stromal keratitis. J. Interferon Cytokine Res. 1998;18:681-690.
11. Kanangat S, Thomas J, Gangappa S, Babu JS, Rouse BT. Herpes simplex virus type 1-mediated up-regulation of IL-12 (p40) mRNA expression. Implications in immunopathogenesis and protection. J. Immunol. 1996;156:1110-1116.
12. Osorio Y, Wechsler SL, Nesburn AB, Ghiasi H. Reduced severity of HSV-1-induced corneal scarring in IL-12-deficient mice. Virus Res. 2002;90:317-326.
13. Watford WT, Hissong RD, Bream JH, Kanno Y, Muul L, O'Shea JJ. Signaling by IL-12 and IL-23 and the immunoregulatory roles of Stat4. Immunol. Rev. 2004;202:139-156.
14. Hoey T, Zhang S, Schmidt N, Yu Q, Ramchandani S, Xu X, Naeger LK, Sun YL, Kaplan MH. Distinct requirements for the naturally occurring splice forms Stat4alpha and Stat4beta in IL-12 responses. EMBO J. 2003;22:4237-4248.
15. Jacobson NG, Szabo SJ, Weber-Nordt RM, Zhong Z, Schreiber RD, Darnell JE Jr, Murphy KM. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4. J. Exp. Med. 1995;181:1755-1762.
16. Bacon CM, Petricoin III EF, Ortaldo JR, Rees RC, Lamer AC, Johnston JA, O'Shea JJ. Interleukin 12 induces tyrosine phosphorylation and activation of Stat4 in human lymphocytes. Proc. Natl. Acad. Sci. USA 1995;92:7307-7311.
17. Gollob JA, Schnipper CP, Murphy EA, Ritz J, Frank DA. The functional synergy between IL-12 and IL-2 involves p38 mitogen-activated protein kinase and is associated with the augmentation of Stat serine phosphorylation. J. Immunol. 1999;162:4472-4481.
18. Yu CR, Lin JX, Fink DW, Akira S, Bloom ET, Yamauchi A. Differential utilization of Janus kinase-signal transducer activator of transcription signaling pathways in the stimulation of human natural killer cells by IL-2, IL-12, and IFN-alpha. J. Immunol. 1996;157:126-137.
19. Zhong Z, Wen Z, Darnell JE Jr. Stat3 and Stat4: members of the family of signal transducers and activators of transcription. Proc. Natl. Acad. Sci. USA 1994;91:4806-4810.
20. Parham C, Chirica M, Timans J, Vaisberg E, Travis M, Cheung J, Pflanz S, Zhang R, Singh KP, Vega F, To W, Wagner J, O'Farrell Am, McClanahan T, Zurawski S, Hannum C, Gorman D, Rennick DM, Kastelein RA, de Waal Malefyt R, Moore KW. A receptor for the heterodimeric cytokine IL-23 is composed of IL-12Rbeta1 and a novel cytokine receptor subunit, IL-23R. J. Immunol. 2002;168:5699-5708.
21. + T cells through Stat1-dependent and -independent mechanisms. Proc. Natl. Acad. Sci. USA 2003;100:15047-15052.
22. Wang KS, Ritz J, Frank DA. IL-2 induces Stat4 activation in primary NK cells and NK cell lines, but not in T cells. J. Immunol. 1999;162:299-304.
23. Strengell M, Matikainen S, Siren J, Lehtonen A, Foster D, Julkunen I, Sareneva T. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 2003;170:5464-5469.
24. Cho SS, Bacon CM, Sudarshan C, Rees RC, Finbloom D, Pine R, O'Shea JJ. Activation of Stat4 by IL-12 and IFN-alpha: evidence for the involvement of ligand-induced tyrosine and serine phosphorylation. J. Immunol. 1996;157:4781-4789.
25. Kaplan MH, Sun YL, Hoey T, Grusby MJ. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice. Nature 1996;382:174-177.
26. Lee S, Zheng M, Deshpande S, Eo SK, Hamilton TA, Rouse BT. IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J. Leukoc. Biol. 2002;71:469-476.
27. Daheshia M, Kuklin N, Kanangat S, Manickan E, Rouse BT. Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J. Immunol. 1997;159:1945-1952.
28. Daheshia M, Kuklin N, Manickan E, Chun S, Rouse BT. Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines. Vaccine 1998;16:1103-1110.
29. Shi HN, Grusby MJ, Nagler-Anderson C. Orally induced peripheral nonresponsiveness is maintained in the absence of functional Th1 or Th2 cells. J. Immunol. 1999;162:5143-5148.
30. Chang HC, Zhang S, Kaplan MH. Neonatal tolerance in the absence of Stat4- and Stat6-dependent Th cell differentiation. J. Immunol. 2002;169:4124-4128.
31. Chitnis T, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Defining Th1 and Th2 immune responses in a reciprocal cytokine environment in vivo. J. Immunol. 2004;172:4260-4265.
32. Chitnis T, Najafian N, Benou C, Salama AD, Grusby MJ, Sayegh MH, Khoury SJ. Effect of targeted disruption of Stat4 and Stat6 on the induction of experimental autoimmune encephalomyelitis. J. Clin. Invest. 2001;108:739-747.
33. Simpson SJ, Shah S, Comiskey M, de Jong YP, Wang B, Mizoguchi E, Bhan AK, Terhorst C. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells. J. Exp. Med. 1998;187:1225-1234.
34. Afanasyeva M, Wang Y, Kaya Z, Stafford EA, Dohmen KM, Sadighi Akha AA, Rose NR. Interleukin-12 receptors/Stat4 signaling is required for the development of autoimmune myocarditis in mice by an interferon-gamma-independent pathway. Circulation 2001;104:3145-3151.
35. -/- BALB/c mice suggests a pathogenic role of Th1 cells. J. Immunol. 2004;172:97-103.
36. Yang Z, Chen M, Ellett JD, Fialkow LB, Carter JD, McDuffie M, Nadler JL. Autoimmune diabetes is blocked in Stat4-deficient mice. J. Autoimmunity 2004;22:191-200.
37. Holz A, Bot A, Coon B, Wolfe T, Grusby MJ, von Herrath MG. Disruption of the Stat4 signaling pathway protects from autoimmune diabetes while retaining antiviral immune competence. J. Immunol. 1999;163:5374-5382.
38. Buxbaum LU, Uzonna JE, Goldschmidt MH, Scott P. Control of new world cutaneous leishmaniasis is IL-12 independent but Stat4 dependent. Eur. J. Immunol. 2002;32:3206-3215.
39. Stamm LM, Satoskar AA, Ghosh SK, David JR, Satoskar AR. Stat4-mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis. Eur. J. Immunol. 1999;29:2524-2529.
40. Tarleton RL, Grusby MJ, Zhang L. Increased susceptibility of Stat4-deficient and enhanced resistance in Stat6-deficient mice to infection with Trypanosoma cruzi. J. Immunol. 2000;165:1520-1525.
41. Cai G, Radzanowski T, Villegas EN, Kastelein R, Hunter CA. Identification of Stat4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J. Immunol. 2000;165:2619-2627.
42. Bot A, Rodrigo E, Wolfe T, Bot S, Von Herrath MG. Infection-triggered regulatory mechanisms override the role of Stat4 in control of the immune response to influenza virus antigens. J. Virol. 2003;77:5794-5800.
43. (+) T cells. J. Exp. Med. 1999;189:1355-1360.
44. Mercadal CM, Bouley DM, DeStephano D, Rouse BT. Herpetic stromal keratitis in the reconstituted scid mouse model. J. Virol. 1993;67:3404-3408.
45. Deshpande S, Zheng M, Lee S, Banerjee K, Gangappa S, Kumaraguru U, Rouse BT. Bystander activation involving T lymphocytes in herpetic stromal keratitis. J. Immunol. 2001;167:2902-2910.
46. Boyton RJ, Davies S, Marden C, Fantino C, Reynolds C, Portugal K, Dewchand H, Altmann DM. Stat4-null non-obese diabetic mice: protection from diabetes and experimental allergic encephalomyelitis, but with concomitant epitope spread. Int. Immunol. 2005;17:1157-1165.
47. Babu JS, Thomas J, Kanangat S, Morrison LA, Knipe DM, Rouse BT. Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J. Virol. 1996;70:101-107.
48. -/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J. Immunol. 2004;172:1237-1245.
49. Zheng M, Deshpande S, Lee S, Ferrara N, Rouse BT. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 2001;75:9828-9835.
50. Fenton RR, Molesworth-Kenyon S, Oakes JE, Lausch RN. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest. Ophthalmol. Vis. Sci. 2002;43:737-743.
51. Keadle TL, Usui N, Laycock KA, Miller JK, Pepose JS, Stuart PM. Il-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 2000;41:96-102.
52. Tang Q, Hendricks RL. Interferon gamma regulates platelet endothelial cell adhesion molecule 1 expression and neutrophil infiltration into herpes simplex virus-infected mouse corneas. J. Exp. Med. 1996;184:1435-1447.
53. Shen XD, Ke B, Zhai Y, Gao F, Anselmo D, Lassman CR, Busuttil RW, Kupiec-Weglinski JW. Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotection. Hepatology 2003;37:296-303.
54. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J. Immunol. 1999;162:3702-3710.
55. Yamamoto K, Shibata F, Miyasaka N, Miura O. The human perforin gene is a direct target of Stat4 activated by IL-12 in NK cells. Biochem. Biophys. Res. Commun. 2002;297:1245-1252.
56. Chang E, Galle L, Maggs D, Estes DM, Mitchell WJ. Pathogenesis of herpes simplex virus type 1-induced corneal inflammation in perforin-deficient mice. J. Virol. 2000;74:11832-11840.
57. + T cells. Immunity 1994;1:553-562.
58. Maertzdorf J, Osterhaus AD, Verjans GM. IL-17 expression in human herpetic stromal keratitis: modulatory effects on chemokine production by corneal fibroblasts. J. Immunol. 2002;169:5897-5903.
59. + T lymphocytes. J. Immunol. 1998;160:3642-3647.